Kyntra Bio KYNB
NASDAQ KYNB
$4.62 -0.50 (-9.77%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) Price to Earnings (2019 - 2026)

Updated

Kyntra Bio's (KYNB) Price to Earnings came in at 0.17 for Q2 2026, down 0.5% from the prior quarter.

Analysis

Kyntra Bio (KYNB) Price to Earnings (2019 - 2026) Analysis & Trends

For FY2025, Kyntra Bio's Price to Earnings stood at 0.19.

  • According to Business Quant data, Price to Earnings for the three prior quarters was 0.17 (Q1 2026), 0.19 (Q4 2025) and 0.23 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Kyntra Bio 18.71 Mn -367.76 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.17
Mar 31, 2026 0.17
Dec 31, 2025 0.19
Sep 30, 2025 0.23
Sep 30, 2019 76.59
Jun 30, 2019 80.09
API Access

Kyntra Bio Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=KYNB&period=max&api_key=YOUR_API_KEY